EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The influence of aluminum and iron status on serum erythropoietin concentrations in hemodialysis patients



The influence of aluminum and iron status on serum erythropoietin concentrations in hemodialysis patients



Nephrology Dialysis Transplantation 10(6): 1050




(PDF emailed within 1 workday: $29.90)

Accession: 033842837

Download citation: RISBibTeXText



Related references

Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum. Gaoxiong Yi Xue Ke Xue Za Zhi 7(3): 126-135, 1991

Serum erythropoietin concentrations and iron status in patients on chronic hemodialysis. Clinical Chemistry 38(2): 199-203, 1992

Effect of aluminum on bioavailability of iron in hemodialysis hd patients treated with recombinant human erythropoietin epo. Clinical & Investigative Medicine 12(SUPPL 4): B66, 1989

Bioavailability of iron in hemodialysis patients treated with erythropoietin: evidence for the inhibitory role of aluminum. American Journal of Kidney Diseases 16(5): 447-451, 1990

Recombinant human erythropoietin resistance in iron-replete hemodialysis patients: role of aluminum toxicity. American Journal of Nephrology 18(1): 1-8, 1998

Diagnostic power of iron status markers in detecting functional iron deficiency in hemodialysis patients on erythropoietin. Nephrology Dialysis Transplantation 15(9): A157, September, 2000

Influence of erythropoietin therapy on aluminum metabolism in chronic hemodialysis patients. Kidney International 37(1): 307, 1990

Aluminum concentrations in serum of hemodialysis patients. Clinical Chemistry 27(6): 932-935, 1981

Serum concentrations of aluminum in hemodialysis patients. American Journal of Kidney Diseases 57(3): 523-525, 2011

Correlation between erythropoietin sensitivity and parameters of iron status in hemodialysis patients. Nephrology Dialysis Transplantation 15(9): A157, September, 2000

Relationship of body iron status and serum aluminum in chronic renal insufficiency patients not taking any aluminum-containing drugs. American Journal of Nephrology 15(2): 118-122, 1995

Iron status and low dose intravenous FeGluconate in hemodialysis patients on maintenance erythropoietin. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 272A, Sept, 1998

Serum erythropoietin levels and body iron stores in hemodialysis patients. Journal of the American Society of Nephrology 4(3): 432, 1993

Serum and lymphocyte nickel and aluminum concentrations in patients with extracorporeal hemodialysis. Annals of Clinical & Laboratory Science 14(5): 413-414, 1984

Targeting higher ferritin concentrations with intravenous iron dextran lowers erythropoietin requirement in hemodialysis patients. Clinical Nephrology 60(5): 335-340, 2003